Healthcare

Latest News

[ May 26, 2022 ] Knightscope to Hold Annual Meeting of Stockholders News Feed
[ May 26, 2022 ] WISeKey Generates the First Ever NFT From Space at Davos Minting a Series of NFTs in WISe.ART Marketplace News Feed
[ May 20, 2022 ] Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line News Feed
[ May 17, 2022 ] Knightscope To Be Used in Fortune 500 Distribution Center News Feed
[ May 17, 2022 ] Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans News Feed
[ May 14, 2022 ] WISeKey Presented the ID Metaverse at the Building Better Worlds China Metaverse Event News Feed
[ May 11, 2022 ] Forrester Research Report Adds StrikeForce’s SafeVchat to List of 25 Secure Communications Providers News Feed

Eyenovia, Inc (NASDAQ: EYEN) Interview with Dr. Sean Ianchulev

September 18, 2018 The Wall Street Analyzer Comments Off

Eyenovia, Inc (NASDAQ: EYEN) CEO: Dr. Sean Ianchulev THIS INTERVIEW HAS EXPIRED

Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth

August 8, 2018 The Wall Street Analyzer Comments Off

Company’s Fourth Consecutive Quarter of Record Revenue and Third Consecutive Quarter with Year-Over-Year Revenue Growth Exceeding 20% […]

Contravir (NASDAQ: CTRV) Interview with CEO James Sapirstein in which he discusses recent funding and CRV431 progress

July 9, 2018 The Wall Street Analyzer Comments Off

Contravir Pharmaceuticals (NASDAQ: CTRV) CEO: James Sapirstein INTERVIEW TRANSCRIPTS: WSA: Good day from Wall Street, this is Juan Costello Senior Analyst with the Wall Street Analyzer. Joining us today is James Sapirstein CEO for […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]